Hubungan Kadar Urea, pH dan Laju Aliran Saliva Pada Penderita Gagal Ginjal Kronik di Klinik Rasyida Medan
55
DAFTAR PUSTAKA
1.
Price SA, Wilson LR. Patofisiologis: konsep klinik proses-proses penyakit.
Alihbahasa. Brahm U. Jakarta: EGC, 2005: 873-9, 899-900, 913-8, 951.
2.
Sudoyo AW, Setiyohadi B, Alwi I, Marcellus SK, Setiati S, eds. Buku ajar ilmu
penyakit dalam. Jakarta: Pusat Penerbitan Departemen Ilmu Penyakit Dalam FK
UI, 2006: 570-1, 574-5, 580.
3.
Morbidity and Mortality Weekly Report. Prevalence of chronic kidney disease
and associated risk factor United States, 1999-2004. (2 Maret 2007)
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5608a2.htm.
(12
Januari
2014).
4.
USA National Kidney Urologic Disease Information Clearinghouse. Kidney
disease statistic for the USA. NIH Publication 2012; 12-2395: 1-7
5.
Badan Penelitian dan Pengembangan Kesehatan Kementerian RI. Riset dasar
kesehatan tahun 2013. Kementerian Kesehatan RI. 2013.
6.
Vesterinen M, Leivo T, Honkanen E, Lindqvist C. Oral health and dental
treatment with renal disease. Quintance International 2007; 38(3): 211-9.
7.
Haider SH, Tanwir F, Momin IA. Oral aspect of chronic renal failure. Pakistan
Oral & Dental Journal 2013; 33(1): 87-90.
8.
Alamo SM, Esteve CG, Perez MGC. Dental consideration for the patient with
renal disease. J Clint Exp Dent 2011; 3(2): 112-9.
9.
Greenberg M, Glick M. Burcket’s oral medicine diagnosis and treatment. Ed.10.
Hamilton Ontario: BC Decker Inc. 2003: 411-9.
10. Almeida PDV,Gregio AMT, Machado MAN, Lima AAS, Azavedo AR. Saliva
composition and functions: acomprehensive review. J Contemp Dent Pract 2008;
(9)3:72-80.
11. Bayraktar G, dkk. Oral health and inflammation in patient with end-stage renal
failure. Peritoneal dyalisis Int 2009; 29: 472-9.
Universitas Sumatera Utara
56
12. Manley KJ, Haryono RY, Keast RSJ. Taste changes and saliva composition in
chronic kidney disease. Renal Society of Australia J 2012; 8(2): 56-60.
13. Tanner GA, Kidney function. In: Roardes RA, David DR. Medical physiology
for clinical medicine. Ed.3. Baltimore: Lippincott Williams & Wilkins, 2008:
391-419.
14. Annonymous.Filtration
membrane.http://courses.washington.edu/conj/bess/filtration/filtration.htm.(13
Januari 2014).
15. Kidney
Health
New
Zealand.
The
Kidney
and
Kidney
Disease.
www.kidney.co.nz/resourses/file/kidney/kidney_and_kidney_disease.pdf.
(20Januari 2014).
16. USH National Kidney Urologic Disease Information Clearinghouse. The kidney
and how they work. NIH Publication; 09-3195: 1-8.
17. Mclyntire N. Acute renal failure. In: Thomas N. Renal nursing. China: 2012:
104-13.
18. Menteri Kesehatan Republik Indonesia. Peraturan menteri kesehatan RI
no.812/MENKES/PER/VII/2010.
19. Carroll LE. The stages of chronic kidney disease and the estimated glomerular
filtration rate. The Journal of Lancaster General Hospital 2006; 1(2): 64-9.
20. The
Kidney
Foundation
in
Canada.
What
is
kidney
disease.http://www.kidney.ca/page.aspx?pid=320. (8 April 2014)
21. The CARI Guidelines. Classification of ckd based on evaluation of kidney
fuction. Evaluation of Renal Funtion 2005: 1.
22. The Management of CKD Working Group Departemen of Veteran Affairs and
Departement of Defence. Va/DoD clinical practice guidelines for management
of ckd. 2007: 11-20.
23. Foothe EF, Manley ED. Hemodialysis and peritoneal dyalisis. In: Dipiro JT,
dkk. Pharmacotheraphy: a pathophysiology approach. Ed.7. New York: The
Mcgraw-Hill Companies Inc, 2008: 103-13.
Universitas Sumatera Utara
57
24. USA National Kidney Urologic Disease Information Clearinghouse. Treatment
methode for kidney failure: Hemodialysis. NIH Publication 2006; 07-4666: 1-9.
25. Glorieux G, Scheper E, Vanholder RC. Uremic toxins in renal failure. Prilozi
Odd Bio Med Nauki 2007; XXVIII: 3-4.
26. Himro.
White
lesion
on
oral
mucosa.
http://dentistryandmedicine.
blogspot.com/2011/11/white-lesions-of-oral-mucosa.html. (13Januari 2014)
27. Simon J, Amde M, Poggie ED. Interpreting the estimated glomerular filtration
rate in primary care: benefits and pitfalls. Cleveland Clinic Journal of Medicine
2011; 78(3): 188-94.
28. Stevens LA, Corresh J, Greene T, Levey AS. Assesing kidney function –
measured and estimated glomerular filtration rate. The New England Medical
Jurnal 2006; 354(23): 2473.
29. Unita L, Lubis HR. Profil lipid penderita ginjal kronik pada predialisis dan
hemodialisis. Majalah Kedokteran Nusantara 2005; 28(2): 163.
30. Indonesia Kidney Care Club. Pengaturan nutrisi untuk penderita ginjal.
http://www.ikcc.or.id/content.php?c=2&id=465. (14 Januari 2014)
31. Hamid MJAA, Dummer CD, Pinto LS, Systemic condition, oral findings and
dental management of chronic renal failure patient. Braz, Dent J 2006; 17(2):
166-70.
32. Whelton H. Introduction: the anatomy and physiology of salivary gland.In : WM
Edgar, DM O’Mullane. Saliva and oral health. London: British Dental
Association, 2004: 1-19, 29.
33. Holsinger CF, Bui DT. Anantomy function and evaluation of salivary gland. In:
Mayer EN, Ferris RL. Salivary gland disorders. Berlin: Springer Berlin
Heildelberg, 2007: 1-13.
34. Catalan AM, Nakamaoto T, Melvin JE. The salivary gland fluid secretion
mechanism. The Journal of Medical Investigation 2009; 56: 24-8.
35. Annonymous. Lecture note on anatomy of salivary gland. (21 September 2011).
http://dentallecnotes.blogspot.com/2011/09/lecture-note-on-anatomy-ofsalivary.html. (21 April 2014).
Universitas Sumatera Utara
58
36. Garett JR, Ekstrom J, Anderson LC. Neural mechanisms of salivary gland
secretion. Basel: Karger, 1999;35-47.
37. Suresh G, Ravi Kiran A, Samata Y, Purnachandrarao Naik N, Vijay Kumar A.
Analisis of blood and salivary urea levels in patient under going haemodyalisis
and kidney transplant. Journal of Clinical and Diagnostic Research 2014;8(7):
18-20.
38. Ekstrom J, dkk. Saliva and the control of its Secretion. Berlin: Springer Verlag,
2012; 20-42.
39. Wong DT. Salivary diagnostic. USA:Wiley-Blackwell. 2008. 60.
40. Kusnanto
MW.
permanganat
Analisis
(KMnO4).
spektroskopi
UV-vis
penentuan
konsentrasi
http://www.share-pdf.com/8a7bfdda05144b139
1261997884cfbdb/laporan-UV-Vis.htm. (19 April 2014).
41. Bambang Madiyono. Perkiraan besar sampel. Dalam: Sastroasmoro S, Ismael S.
Dasar-dasar metodologi penelitian klinis. Ed.4. Jakarta: Sagung Seto, 2011: 359.
42. Bossola M, Tazza L. Xerostomia in patient chronic hemodialysis Nature
Reviews : Nephrology 2012; 8: 176-81.
43. Kaushik A, Reddy SS, Umesh L, Devi BKY, Santana N, Rakesh N. Oral and
salivary changes among renal patient undergoing hemodialysis : a cross
sectional study. Indian Journal of Nephrology 2013;23(2): 125-9.
44. Wang LJ. Chen CK. The psycological impacts of hemodialysis on patients with
chronic kidney disease. In: Polenakovic. Renal failure : the facts,
Rijeka:
InTech, 2012: 217, 219, 222, 224.
45. Rohleder N, Wolf JM, Maldonado EF, Kirschbaum C. The psychososial stressinduced increase of salivary alpha-amylase is independent of salivary flow rat
e.Psychophysiology 2006; 43: 645-6.
Universitas Sumatera Utara
DAFTAR PUSTAKA
1.
Price SA, Wilson LR. Patofisiologis: konsep klinik proses-proses penyakit.
Alihbahasa. Brahm U. Jakarta: EGC, 2005: 873-9, 899-900, 913-8, 951.
2.
Sudoyo AW, Setiyohadi B, Alwi I, Marcellus SK, Setiati S, eds. Buku ajar ilmu
penyakit dalam. Jakarta: Pusat Penerbitan Departemen Ilmu Penyakit Dalam FK
UI, 2006: 570-1, 574-5, 580.
3.
Morbidity and Mortality Weekly Report. Prevalence of chronic kidney disease
and associated risk factor United States, 1999-2004. (2 Maret 2007)
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5608a2.htm.
(12
Januari
2014).
4.
USA National Kidney Urologic Disease Information Clearinghouse. Kidney
disease statistic for the USA. NIH Publication 2012; 12-2395: 1-7
5.
Badan Penelitian dan Pengembangan Kesehatan Kementerian RI. Riset dasar
kesehatan tahun 2013. Kementerian Kesehatan RI. 2013.
6.
Vesterinen M, Leivo T, Honkanen E, Lindqvist C. Oral health and dental
treatment with renal disease. Quintance International 2007; 38(3): 211-9.
7.
Haider SH, Tanwir F, Momin IA. Oral aspect of chronic renal failure. Pakistan
Oral & Dental Journal 2013; 33(1): 87-90.
8.
Alamo SM, Esteve CG, Perez MGC. Dental consideration for the patient with
renal disease. J Clint Exp Dent 2011; 3(2): 112-9.
9.
Greenberg M, Glick M. Burcket’s oral medicine diagnosis and treatment. Ed.10.
Hamilton Ontario: BC Decker Inc. 2003: 411-9.
10. Almeida PDV,Gregio AMT, Machado MAN, Lima AAS, Azavedo AR. Saliva
composition and functions: acomprehensive review. J Contemp Dent Pract 2008;
(9)3:72-80.
11. Bayraktar G, dkk. Oral health and inflammation in patient with end-stage renal
failure. Peritoneal dyalisis Int 2009; 29: 472-9.
Universitas Sumatera Utara
56
12. Manley KJ, Haryono RY, Keast RSJ. Taste changes and saliva composition in
chronic kidney disease. Renal Society of Australia J 2012; 8(2): 56-60.
13. Tanner GA, Kidney function. In: Roardes RA, David DR. Medical physiology
for clinical medicine. Ed.3. Baltimore: Lippincott Williams & Wilkins, 2008:
391-419.
14. Annonymous.Filtration
membrane.http://courses.washington.edu/conj/bess/filtration/filtration.htm.(13
Januari 2014).
15. Kidney
Health
New
Zealand.
The
Kidney
and
Kidney
Disease.
www.kidney.co.nz/resourses/file/kidney/kidney_and_kidney_disease.pdf.
(20Januari 2014).
16. USH National Kidney Urologic Disease Information Clearinghouse. The kidney
and how they work. NIH Publication; 09-3195: 1-8.
17. Mclyntire N. Acute renal failure. In: Thomas N. Renal nursing. China: 2012:
104-13.
18. Menteri Kesehatan Republik Indonesia. Peraturan menteri kesehatan RI
no.812/MENKES/PER/VII/2010.
19. Carroll LE. The stages of chronic kidney disease and the estimated glomerular
filtration rate. The Journal of Lancaster General Hospital 2006; 1(2): 64-9.
20. The
Kidney
Foundation
in
Canada.
What
is
kidney
disease.http://www.kidney.ca/page.aspx?pid=320. (8 April 2014)
21. The CARI Guidelines. Classification of ckd based on evaluation of kidney
fuction. Evaluation of Renal Funtion 2005: 1.
22. The Management of CKD Working Group Departemen of Veteran Affairs and
Departement of Defence. Va/DoD clinical practice guidelines for management
of ckd. 2007: 11-20.
23. Foothe EF, Manley ED. Hemodialysis and peritoneal dyalisis. In: Dipiro JT,
dkk. Pharmacotheraphy: a pathophysiology approach. Ed.7. New York: The
Mcgraw-Hill Companies Inc, 2008: 103-13.
Universitas Sumatera Utara
57
24. USA National Kidney Urologic Disease Information Clearinghouse. Treatment
methode for kidney failure: Hemodialysis. NIH Publication 2006; 07-4666: 1-9.
25. Glorieux G, Scheper E, Vanholder RC. Uremic toxins in renal failure. Prilozi
Odd Bio Med Nauki 2007; XXVIII: 3-4.
26. Himro.
White
lesion
on
oral
mucosa.
http://dentistryandmedicine.
blogspot.com/2011/11/white-lesions-of-oral-mucosa.html. (13Januari 2014)
27. Simon J, Amde M, Poggie ED. Interpreting the estimated glomerular filtration
rate in primary care: benefits and pitfalls. Cleveland Clinic Journal of Medicine
2011; 78(3): 188-94.
28. Stevens LA, Corresh J, Greene T, Levey AS. Assesing kidney function –
measured and estimated glomerular filtration rate. The New England Medical
Jurnal 2006; 354(23): 2473.
29. Unita L, Lubis HR. Profil lipid penderita ginjal kronik pada predialisis dan
hemodialisis. Majalah Kedokteran Nusantara 2005; 28(2): 163.
30. Indonesia Kidney Care Club. Pengaturan nutrisi untuk penderita ginjal.
http://www.ikcc.or.id/content.php?c=2&id=465. (14 Januari 2014)
31. Hamid MJAA, Dummer CD, Pinto LS, Systemic condition, oral findings and
dental management of chronic renal failure patient. Braz, Dent J 2006; 17(2):
166-70.
32. Whelton H. Introduction: the anatomy and physiology of salivary gland.In : WM
Edgar, DM O’Mullane. Saliva and oral health. London: British Dental
Association, 2004: 1-19, 29.
33. Holsinger CF, Bui DT. Anantomy function and evaluation of salivary gland. In:
Mayer EN, Ferris RL. Salivary gland disorders. Berlin: Springer Berlin
Heildelberg, 2007: 1-13.
34. Catalan AM, Nakamaoto T, Melvin JE. The salivary gland fluid secretion
mechanism. The Journal of Medical Investigation 2009; 56: 24-8.
35. Annonymous. Lecture note on anatomy of salivary gland. (21 September 2011).
http://dentallecnotes.blogspot.com/2011/09/lecture-note-on-anatomy-ofsalivary.html. (21 April 2014).
Universitas Sumatera Utara
58
36. Garett JR, Ekstrom J, Anderson LC. Neural mechanisms of salivary gland
secretion. Basel: Karger, 1999;35-47.
37. Suresh G, Ravi Kiran A, Samata Y, Purnachandrarao Naik N, Vijay Kumar A.
Analisis of blood and salivary urea levels in patient under going haemodyalisis
and kidney transplant. Journal of Clinical and Diagnostic Research 2014;8(7):
18-20.
38. Ekstrom J, dkk. Saliva and the control of its Secretion. Berlin: Springer Verlag,
2012; 20-42.
39. Wong DT. Salivary diagnostic. USA:Wiley-Blackwell. 2008. 60.
40. Kusnanto
MW.
permanganat
Analisis
(KMnO4).
spektroskopi
UV-vis
penentuan
konsentrasi
http://www.share-pdf.com/8a7bfdda05144b139
1261997884cfbdb/laporan-UV-Vis.htm. (19 April 2014).
41. Bambang Madiyono. Perkiraan besar sampel. Dalam: Sastroasmoro S, Ismael S.
Dasar-dasar metodologi penelitian klinis. Ed.4. Jakarta: Sagung Seto, 2011: 359.
42. Bossola M, Tazza L. Xerostomia in patient chronic hemodialysis Nature
Reviews : Nephrology 2012; 8: 176-81.
43. Kaushik A, Reddy SS, Umesh L, Devi BKY, Santana N, Rakesh N. Oral and
salivary changes among renal patient undergoing hemodialysis : a cross
sectional study. Indian Journal of Nephrology 2013;23(2): 125-9.
44. Wang LJ. Chen CK. The psycological impacts of hemodialysis on patients with
chronic kidney disease. In: Polenakovic. Renal failure : the facts,
Rijeka:
InTech, 2012: 217, 219, 222, 224.
45. Rohleder N, Wolf JM, Maldonado EF, Kirschbaum C. The psychososial stressinduced increase of salivary alpha-amylase is independent of salivary flow rat
e.Psychophysiology 2006; 43: 645-6.
Universitas Sumatera Utara